More specifically, it seems to be a combination of: documenting the medical needs of patients (probably through intake forms) who are experiencing or have experienced nausea, vomiting, or other drug tolerance-related issues associated with GLP-1s (which are discussed in this Hims paper), and providing personalized compounded semaglutide in doses outside the 10% threshold to address those documented medical needs
The dose youre prescribed will probably depend on what stage of treatment youre at
The STEP 1 trial for semaglutide 2.4mg showed 14.9% average weight loss at 68 weeks
Make Nutrition Easier While You Figure Out Medications Whether you're starting an antidepressant, considering Contrave, or simply trying to eat better, consistency in your nutrition intake matters more than anything
If a pen has been left unrefrigerated beyond the manufacturer's specified timeframe (Ozempic: 56 days
If drug shortages are making it hard to stay on your GLP-1, talk to your doctor